Top compounds associated with response to SPRY4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:piperlongumine (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.23	1e-09
mRNA	AZD6244	CTRPv2	pan-cancer	AAC	0.24	5e-10
mRNA	dabrafenib	GDSC1000	pan-cancer	AAC	0.21	3e-10
mRNA	selumetinib:BRD-A02303741 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.24	2e-10
mRNA	PD-0325901	gCSI	pan-cancer	AAC	0.4	8e-11
mRNA	VX-11e	GDSC1000	pan-cancer	AAC	0.23	8e-11
mRNA	selumetinib:UNC0638 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.26	1e-11
mRNA	selumetinib:PLX-4032 (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.26	1e-11
mRNA	PD-0325901	CCLE	pan-cancer	AAC	0.33	5e-12
mRNA	GSK1120212	CTRPv2	pan-cancer	AAC	0.35	3e-12

Download CSV